Published in Addict Behav on August 30, 2002
A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychol Bull (2009) 2.08
Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. Arch Gen Psychiatry (2010) 1.17
Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment. Neuropsychopharmacology (2013) 1.03
Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence. Biol Psychiatry (2012) 1.02
Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Neurosci Biobehav Rev (2012) 1.01
The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men. Appetite (2013) 0.96
Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world. Contemp Clin Trials (2012) 0.96
Event-related potentials indicate motivational relevance of cocaine cues in abstinent cocaine addicts. Psychopharmacology (Berl) (2004) 0.94
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials (2014) 0.92
Effect of telaprevir on the pharmacokinetics of buprenorphine in volunteers on stable buprenorphine/naloxone maintenance therapy. Antimicrob Agents Chemother (2012) 0.88
Attentional bias for prescription opioid cues among opioid dependent chronic pain patients. J Behav Med (2012) 0.84
Cue-induced craving in dependence upon prescription opioids and heroin. Am J Addict (2014) 0.82
Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings. Transl Psychiatry (2013) 0.81
Pharmacokinetic interaction between telaprevir and methadone. Antimicrob Agents Chemother (2013) 0.81
Prefrontal hypoactivity associated with impaired inhibition in stimulant-dependent individuals but evidence for hyperactivation in their unaffected siblings. Neuropsychopharmacology (2013) 0.80
Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands. BMC Psychiatry (2011) 0.78
Psychometric properties of the Chinese craving beliefs questionnaire for heroin abusers in methadone treatment. BMC Psychiatry (2011) 0.77
Effect of craving induction on inhibitory control in opiate dependence. Psychopharmacology (Berl) (2011) 0.76
Take it or leave it: prefrontal control in recreational cocaine users. Transl Psychiatry (2015) 0.76
The Obsessive Compulsive Cocaine Scale: assessment of factor structure, reliability, and validity. Addict Behav (2011) 0.76
Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain. Drug Alcohol Depend (2014) 0.76
Disentangling psychopathology, substance use and dependence: a factor analysis. BMC Psychiatry (2016) 0.75
Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study. BMC Psychiatry (2015) 0.75
Exploring Neural Correlates of Different Dimensions in Drug Craving Self-Reports among Heroin Dependents. Basic Clin Neurosci (2015) 0.75
An Exploration of Responses to Drug Conditioned Stimuli during Treatment for Substance Dependence. J Addict (2013) 0.75
Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict (2017) 0.75
No Clinically Relevant Drug-Drug Interactions Between Methadone or Buprenorphine/Naloxone and Anti-Viral Combination Glecaprevir and Pibrentasvir. Antimicrob Agents Chemother (2017) 0.75
Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals. Psychopharmacology (Berl) (2017) 0.75
Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction (2006) 2.23
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction (2014) 2.16
Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry (2012) 2.10
Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89
Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V? Addiction (2006) 1.88
Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res (2005) 1.88
Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. J Psychopharmacol (2013) 1.79
Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction (2012) 1.78
Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend (2005) 1.69
Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev (2009) 1.66
Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry (2012) 1.66
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry (2007) 1.62
Attentional bias predicts heroin relapse following treatment. Addiction (2006) 1.61
Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. Biol Psychiatry (2012) 1.58
What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev (2003) 1.57
Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology (2008) 1.56
SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry (2002) 1.54
Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. Am J Psychiatry (2005) 1.52
Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biol Psychiatry (2013) 1.49
Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. Addiction (2009) 1.46
Are scratchcards addictive? The prevalence of pathological scratchcard gambling among adult scratchcard buyers in the Netherlands. Addiction (2003) 1.46
Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci (2013) 1.45
Screening for Posttraumatic Stress Disorder: an evaluation of two self-report scales among crime victims. Psychol Assess (2003) 1.44
Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage (2011) 1.41
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health (2007) 1.40
Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol (2005) 1.39
Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend (2011) 1.36
Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol (2010) 1.36
The relationship between impulsive choice and impulsive action: a cross-species translational study. PLoS One (2012) 1.33
Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol (2010) 1.30
Properties of the Hopkins Symptom Checklist-25 (HSCL-25) and the Self-Reporting Questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan. Soc Psychiatry Psychiatr Epidemiol (2007) 1.29
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol (2013) 1.27
The COMT val158met polymorphism and brain morphometry in healthy young adults. Neurosci Lett (2006) 1.25
Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ (2005) 1.23
Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med (2008) 1.23
Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biol Psychiatry (2012) 1.23
Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents. Biol Psychiatry (2006) 1.21
Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol (2006) 1.21
Dialectical Behavior Therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav (2002) 1.20
A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend (2004) 1.20
Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behav Res Ther (2005) 1.19
Psychiatric disorders in detained male adolescents: a systematic literature review. Can J Psychiatry (2010) 1.16
Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review. Eur Child Adolesc Psychiatry (2006) 1.16
Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. Eur Addict Res (2010) 1.15
Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug Alcohol Depend (2006) 1.15
Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry (2009) 1.14
Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug Alcohol Depend (2008) 1.14
Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology (Berl) (2004) 1.13
Measuring craving: an attempt to connect subjective craving with cue reactivity. Alcohol Clin Exp Res (2006) 1.13
Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry (2002) 1.13
Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. Psychopharmacology (Berl) (2003) 1.11
An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addiction (2002) 1.09
Psychiatric disorders in a representative sample of incarcerated boys in the Netherlands. J Am Acad Child Adolesc Psychiatry (2004) 1.09
Decision-making deficits in alcohol-dependent patients with and without comorbid personality disorder. Alcohol Clin Exp Res (2006) 1.08
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain (2008) 1.08
N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology (2012) 1.07
The association between neighborhood disorder, social cohesion and hazardous alcohol use: a national multilevel study. Drug Alcohol Depend (2012) 1.07
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry (2011) 1.06
Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol (2008) 1.06
Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. Drug Alcohol Depend (2011) 1.06
Neurobiological substrate of smoking-related attentional bias. Neuroimage (2010) 1.06
Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord (2011) 1.04
Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. Drug Alcohol Depend (2009) 1.04
Effects of non-invasive neurostimulation on craving: a meta-analysis. Neurosci Biobehav Rev (2013) 1.04
Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend (2013) 1.03
Response inhibition during cue reactivity in problem gamblers: an fMRI study. PLoS One (2012) 1.03
'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. Int J Drug Policy (2012) 1.02
Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend (2005) 1.01
The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the Craving Withdrawal Model. Addiction (2006) 1.01
Mental health differences between frequent cannabis users with and without dependence and the general population. Addiction (2013) 1.00
Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial. Psychother Psychosom (2007) 0.99
Brain imaging studies in pathological gambling. Curr Psychiatry Rep (2010) 0.99
Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol (2006) 0.99
A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol (2005) 0.99
Neural responses associated with cue-reactivity in frequent cannabis users. Addict Biol (2012) 0.98
Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders. J Nerv Ment Dis (2009) 0.98
A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology (2006) 0.96
Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addict Biol (2012) 0.96
Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. Addict Biol (2009) 0.96
The role of dopamine in human addiction: from reward to motivated attention. Eur J Pharmacol (2005) 0.96
The high harm score of alcohol. Time for drug policy to be revisited? J Psychopharmacol (2013) 0.95
Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials. Addiction (2005) 0.95
Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study. Drug Alcohol Depend (2008) 0.95
Innovations in agonist maintenance treatment of opioid-dependent patients. Curr Opin Psychiatry (2006) 0.94
The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcohol Clin Exp Res (2005) 0.94
Approach-bias predicts development of cannabis problem severity in heavy cannabis users: results from a prospective FMRI study. PLoS One (2012) 0.94
Behavioural aspects of impulsivity in alcoholics with and without a cluster-B personality disorder. Alcohol Alcohol (2006) 0.94
Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophr Res (2012) 0.93
The craving withdrawal model for alcoholism: towards the DSM-V. Improving the discriminant validity of alcohol use disorder diagnosis. Alcohol Alcohol (2005) 0.93
Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) (2004) 0.93
Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. Eur Addict Res (2011) 0.92
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (2013) 0.92
Origin of the comorbidity of anxiety disorders and alcohol dependence: findings of a general population study. Eur Addict Res (2007) 0.92
Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend (2002) 0.92
Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol (2006) 0.92
Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology (2005) 0.92
Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications. Addiction (2010) 0.91
Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. Drug Alcohol Depend (2011) 0.91
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology (Berl) (2011) 0.91
A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. Drug Alcohol Depend (2012) 0.90